NextGenNK Press Releases 2020
First collaboration between partners in the NextGenNK competence center
Avectas and Vycellix Announce Collaboration to Advance Next-Generation Solutions for the Optimized Manufacture of Cell & Gene Therapies. NextGenNK catalyzed interaction among its industrial partners to advance NK cell-based immunotherapies.
First collaboration between partners in the NextGenNK competence center
N盲ringslivet sluter upp f枚r utveckling av immunterapi
Tio svenska och internationella f枚retag har nu gemensamt g氓tt ihop med forskare fr氓n 探花精选 (KI) f枚r att samverka kring utveckling av n盲sta generations NK cells-baserade immunterapi mot cancersjukdomar.
N盲ringslivet sluter upp f枚r utveckling av immunterapi
New Centre of Excellence at KI for treatment of cancer
探花精选 is granted funding from Vinnova to start a new centre of excellence. The centre will focus on developing next-generation immunotherapy based on NK-cells for the treatment of cancer.